Ceres Pharma has acquired CEUMED, a pharmaceutical and cosmetics group operating in six CEE and SEE countries, to enhance its product portfolio and expand into new markets.
Target Information
CEUMED is a pharmaceutical and cosmetics group that specializes in the production, marketing, and distribution of over-the-counter (OTC) and cosmetic products. The company operates across six countries in Central and Eastern Europe (CEE) and Southeast Europe (SEE). With a strong focus on expanding its product portfolio and market reach, CEUMED has established itself as a key player in the region’s health and beauty sector.
Recently, CEUMED has been acquired by Ceres Pharma, a Belgian-based company known for its rapid growth and strategic acquisitions. Founded by the former owners of Omega Pharma, Ceres Pharma has generated €130 million in revenue and has expanded its presence into seven countries, completing a total of twelve acquisitions between 2018 and 2023. This strategic acquisition positions Ceres Pharma to leverage CEUMED's capabilities and market access.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The pharmaceutical and cosmetics industry in the CEE and SEE regions has shown resilience and growth potential, particularly in the OTC segment. Unlike Western Europe, where market gro
Similar Deals
Ceres Pharma
invested in
CEUMED
in 2023
in a Buyout deal
Disclosed details
Revenue: $143M